Clinical trial • Oncology
Clinical trial in Breast cancer
Clinical trial for Breast cancer. 155 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Breast cancer
Key dates
- Initial CTIS Submission Date
- 13-09-2024
- First CTIS Authorization Date
- 02-10-2024
Trial design
Clinical trial across 4 sites in France.
- Target Sample Size
- 155
Eligibility
Recruits 155 Vulnerable population not selected; no special consent/assent handling described..
- Vulnerable Population
- Vulnerable population not selected; no special consent/assent handling described.
Recruitment
- Planned Sample Size
- 155
- Recruitment Window Months
- 114
Geography
- Total Number Of Sites
- 4
- Total Number Of Participants
- 155
France
- Earliest CTIS Part Ii Submission Date
- 27-09-2024
- Latest Decision Or Authorization Date
- 23-04-2026
- Processing Time Days
- 573
- Number Of Sites
- 4
- Number Of Participants
- 155
Sites
- Site Name
- Centre Hospitalier D'Antibes Juan Les Pins
- Department Name
- Oncology
- Contact Person Name
- Kenza BOUREDJI
- Contact Person Email
- kenza.bouredji@ch-antibes.fr
- Site Name
- Centre Antoine Lacassagne
- Department Name
- Oncology
- Contact Person Name
- Anne CREISSON
- Contact Person Email
- anne.creisson@nice.unicancer.fr
- Site Name
- Centre azureen de cancerologie
- Department Name
- Oncology
- Contact Person Name
- Remi LARGILLIER
- Contact Person Email
- r.largillier@gmail.com
- Site Name
- Polyclinique Saint George
- Department Name
- Medical Oncology
- Contact Person Name
- Ophélie CASSUTO
- Contact Person Email
- ophelie.cassuto@clinique-saint-george.com
Sponsor
Primary sponsor
- Full Name
- Centre Antoine Lacassagne
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- France
Related trials
Other published trials that may interest you.